Detalhe da pesquisa
1.
Delamanid Central Nervous System Pharmacokinetics in Tuberculous Meningitis in Rabbits and Humans.
Antimicrob Agents Chemother
; 63(10)2019 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-31383662
2.
Long COVID in low-income and middle-income countries: the hidden public health crisis.
Lancet
; 402(10408): 1115-1117, 2023 09 30.
Artigo
em Inglês
| MEDLINE | ID: mdl-37652071
3.
Multidrug-Resistant Tuberculosis Treatment Outcomes in Relation to Treatment and Initial Versus Acquired Second-Line Drug Resistance.
Clin Infect Dis
; 62(4): 418-430, 2016 Feb 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-26508515
4.
Additional drug resistance of multidrug-resistant tuberculosis in patients in 9 countries.
Emerg Infect Dis
; 21(6): 977-83, 2015 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-25988299
5.
Association between Regimen Composition and Treatment Response in Patients with Multidrug-Resistant Tuberculosis: A Prospective Cohort Study.
PLoS Med
; 12(12): e1001932, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26714320
6.
Extensive drug resistance acquired during treatment of multidrug-resistant tuberculosis.
Clin Infect Dis
; 59(8): 1049-63, 2014 Oct 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-25057101
7.
Bedaquiline-pretomanid-moxifloxacin-pyrazinamide for drug-sensitive and drug-resistant pulmonary tuberculosis treatment: a phase 2c, open-label, multicentre, partially randomised controlled trial.
Lancet Infect Dis
; 2024 May 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-38768617
8.
Prevalence of and risk factors for resistance to second-line drugs in people with multidrug-resistant tuberculosis in eight countries: a prospective cohort study.
Lancet
; 380(9851): 1406-17, 2012 Oct 20.
Artigo
em Inglês
| MEDLINE | ID: mdl-22938757
9.
An international observational study to assess the impact of the Omicron variant emergence on the clinical epidemiology of COVID-19 in hospitalised patients.
Elife
; 112022 10 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-36197074
10.
Resistance to second-line drugs in multidrug-resistant tuberculosis - Authors' reply.
Lancet
; 381(9867): 626, 2013 Feb 23.
Artigo
em Inglês
| MEDLINE | ID: mdl-23439099
11.
Efficacy and safety of delamanid in combination with an optimised background regimen for treatment of multidrug-resistant tuberculosis: a multicentre, randomised, double-blind, placebo-controlled, parallel group phase 3 trial.
Lancet Respir Med
; 7(3): 249-259, 2019 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-30630778
12.
Estimating the future burden of multidrug-resistant and extensively drug-resistant tuberculosis in India, the Philippines, Russia, and South Africa: a mathematical modelling study.
Lancet Infect Dis
; 17(7): 707-715, 2017 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-28499828
13.
Sputum culture conversion as a prognostic marker for end-of-treatment outcome in patients with multidrug-resistant tuberculosis: a secondary analysis of data from two observational cohort studies.
Lancet Respir Med
; 3(3): 201-9, 2015 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-25726085
14.
Weight gain and response to treatment for multidrug-resistant tuberculosis.
Am J Trop Med Hyg
; 89(5): 943-9, 2013 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-24019430
15.
Design and implementation of an HIV/AIDS electronic medical record system (HIV/AIDS EMR) in the Philippines.
AMIA Annu Symp Proc
; : 1166, 2007 Oct 11.
Artigo
em Inglês
| MEDLINE | ID: mdl-18694262
16.
Evaluation of the TB-Biochip oligonucleotide microarray system for rapid detection of rifampin resistance in Mycobacterium tuberculosis.
J Clin Microbiol
; 44(7): 2378-81, 2006 Jul.
Artigo
em Inglês
| MEDLINE | ID: mdl-16825352